Skip to content
Screener

Pacira BioSciences, Inc. PCRX Intangibles (Net)

Intangibles (Net) at other companies

Anika Therapeutics logo
Anika TherapeuticsANIK
$1.65M-0.7%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$1.19B+52.0%
AtriCure logo
AtriCureATRC
$43.26M-17.2%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$997.34M-14.0%
Enterprise value$1.26B+4.9%
P/E194.1×—
P/S1.4×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028871
March 31, 2026Gross Carrying ValueAccumulated AmortizationIntangible Assets, NetWeighted-Average Useful Lives
Developed technologies$590,000$(270,533)$319,46710 years, 5 months
Customer relationships90(63)2710 years
Total finite-lived intangible assets, net590,090(270,596)319,494
Acquired IPR&D (1)33,733—33,733
Total intangible assets, net$623,823$(270,596)$353,227
(1) The change in the gross carrying value reflects the impact of foreign currency translation adjustments related to the GQ Bio acquired IPR&D.

Item 1. FINANCIAL STATEMENTS (Unaudited)

FAQ

What is Pacira BioSciences, Inc.'s intangibles (net)?
Pacira BioSciences, Inc. (PCRX) reported intangibles (net) of $319.49M in Q1 2026.
How has Pacira BioSciences, Inc.'s intangibles (net) changed year-over-year?
Pacira BioSciences, Inc.'s intangibles (net) decreased by 15.2% year-over-year, from $376.78M to $319.49M.
What is the long-term trend for Pacira BioSciences, Inc.'s intangibles (net)?
Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s intangibles (net) has grown at a 28.2% compound annual growth rate (CAGR), from $96.52M to $333.82M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Ask your AI about Pacira BioSciences, Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude